使用F-FDG PET/CT对接受检查点抑制剂治疗的患者的超进展性疾病进行诊断。 - Suppr

Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using F-FDG PET/CT.

作者信息

Seban Romain-David, Schwartz Lawrence H, Bonardel Gerald, Dercle Laurent

机构信息

Department of Radiology at Columbia University Medical Center/NewYork-Presbyterian Hospital 168th St. New York, NY 10032 E-mail:

出版信息

J Nucl Med. 2020 Sep;61(9):1404-1405. doi: 10.2967/jnumed.120.242768. Epub 2020 Feb 21.

DOI:10.2967/jnumed.120.242768

PMID:32086243

Abstract

摘要

相似文献

Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using F-FDG PET/CT.使用F-FDG PET/CT对接受检查点抑制剂治疗的患者的超进展性疾病进行诊断。

J Nucl Med. 2020 Sep;61(9):1404-1405. doi: 10.2967/jnumed.120.242768. Epub 2020 Feb 21.

Reply: Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using F-FDG PET/CT.回复：使用F-FDG PET/CT对接受检查点抑制剂治疗的患者进行超进展性疾病的诊断。

J Nucl Med. 2020 Sep;61(9):1405. doi: 10.2967/jnumed.120.243444. Epub 2020 Mar 13.

Hyperprogressive Disease in Patients with Non-Small Cell Lung Cancer Treated with Checkpoint Inhibitors: The Role of F-FDG PET/CT.接受检查点抑制剂治疗的非小细胞肺癌患者的超进展性疾病：F-FDG PET/CT 的作用。

J Nucl Med. 2020 Jun;61(6):821-826. doi: 10.2967/jnumed.119.237768. Epub 2019 Dec 20.

Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.F18-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描在非小细胞肺癌潜在根治性手术后患者中的临床价值：241例患者的经验

Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.

Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.氟 18 氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对非小细胞肺癌患者转移灶的诊断价值。

Int J Cancer. 2013 Jan 15;132(2):E37-47. doi: 10.1002/ijc.27779. Epub 2012 Sep 1.

Reply: Repeatability of Quantitative Whole-Body F-FDG PET/CT Uptake Measures in Patients with Non-Small Cell Lung Cancer: Dynamic Versus Test-Retest Design.回复：非小细胞肺癌患者全身 F-FDG PET/CT 定量摄取测量的可重复性：动态设计与重测设计对比

J Nucl Med. 2017 Sep;58(9):1528-1529. doi: 10.2967/jnumed.117.195461. Epub 2017 Jun 15.

[Target volume reduction by F-FDG-PET/CT-based involved-field irradiation of advanced non-small cell lung cancer possible new standard: results of the PET-plan study].[基于F-FDG-PET/CT的累及野照射实现晚期非小细胞肺癌靶区体积缩减：可能成为新标准：PET计划研究结果]

Strahlenther Onkol. 2020 Aug;196(8):743-746. doi: 10.1007/s00066-020-01643-7.

Thoracic staging with F-FDG PET/MR in non-small cell lung cancer - does it change therapeutic decisions in comparison to F-FDG PET/CT?非小细胞肺癌中使用F-FDG PET/MR进行胸部分期——与F-FDG PET/CT相比，它是否会改变治疗决策？

Eur Radiol. 2017 Feb;27(2):681-688. doi: 10.1007/s00330-016-4397-0. Epub 2016 May 14.

Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.非小细胞肺癌的纵隔分期：计算机断层扫描与F-18-氟脱氧葡萄糖正电子发射断层扫描及计算机断层扫描对比

Cancer Imaging. 2014 Jun 3;14(1):23. doi: 10.1186/1470-7330-14-23.

Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.非小细胞肺癌患者的不一致发现：骨扫描完全正常与正电子发射断层扫描/计算机断层扫描显示广泛骨转移。

Eur J Cardiothorac Surg. 2010 Apr;37(4):792-6. doi: 10.1016/j.ejcts.2009.11.011. Epub 2009 Dec 16.

引用本文的文献

Integrating [F]-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography with Radiation Therapy and Immunomodulation in Precision Therapy for Solid Tumors.在实体瘤精准治疗中整合[F]-氟脱氧葡萄糖正电子发射断层扫描与计算机断层扫描以及放射治疗和免疫调节

Cancers (Basel). 2023 Oct 27;15(21):5179. doi: 10.3390/cancers15215179.

Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [F]FDG PET/CT imaging during immunomodulatory treatments in patients with solid tumors version 1.0.《EANM/SNMMI/ANZSNM 联合实践指南/程序标准：在实体瘤患者接受免疫调节治疗期间推荐使用 [F]FDG PET/CT 成像（第 1.0 版）》

Eur J Nucl Med Mol Imaging. 2022 Jun;49(7):2323-2341. doi: 10.1007/s00259-022-05780-2. Epub 2022 Apr 4.

Interpretation of 2-[F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors.免疫检查点抑制剂治疗霍奇金淋巴瘤患者的 2-[F]FDG PET/CT 解读。

Eur Radiol. 2022 Sep;32(9):6536-6544. doi: 10.1007/s00330-022-08669-8. Epub 2022 Mar 28.

Potential Theranostic Role of Bone Marrow Glucose Metabolism on Baseline F-FDG PET/CT in Metastatic Melanoma.骨髓葡萄糖代谢在转移性黑色素瘤基线F-FDG PET/CT中的潜在诊疗作用

J Nucl Med. 2022 Jan;63(1):166. doi: 10.2967/jnumed.121.262361. Epub 2021 May 28.

The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma.18F-FDG PET/CT在指导浸润性膀胱癌精准医学中的作用

Front Oncol. 2020 Oct 6;10:565086. doi: 10.3389/fonc.2020.565086. eCollection 2020.

Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab.使用基线氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（FDG-PET/CT）代谢评分和中性粒细胞与淋巴细胞比值（dNLR）与一线帕博利珠单抗治疗的晚期非小细胞肺癌（NSCLC）患者免疫治疗结果的相关性

Cancers (Basel). 2020 Aug 10;12(8):2234. doi: 10.3390/cancers12082234.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using F-FDG PET/CT.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献